Your Source for Venture Capital and Private Equity Financings

Select An Article

Formic Pulls In $27.4M Series A Round
2024-06-25
CHICAGO, IL, Formic, a provider of Robots-as-a-Service (RaaS) automation for U.S. manufacturers, today announced it has raised another $27.4 million in Series A financing.
Read More
Foray Bioscience Raises $3M Seed Financing
2024-06-25
CAMBRIDGE, MA, Foray Bioscience, a startup sowing the seeds for plantless plant products, today announced it has raised $3 million in seed funding, led by ReGen Ventures.
Read More
Coder Grabs $35M Series B2 Round
2024-06-25
AUSTIN, TX, Coder today announced it has secured $35 million in capital to broaden its open source footprint, evolve cloud development environments (CDEs), and expand globally.
Read More
Arrow Emerges With $110M
2024-06-25
NEW YORK, NY, Arrow, a cutting-edge healthcare technology company, is proud to announce its official launch, bolstered by $110 million in Series A funding secured in 2022.
Read More
Daytona Scores $5M Seed Round
2024-06-25
NEW YORK, NY, Daytona, an open source development environment manager, announces today that it has secured $5 million in seed funding to fuel its mission of democratizing development for developers globally.
Read More
Bright Machines Scoops Up $126M Series C
2024-06-25
SAN FRANCISCO, CA, Bright Machines, an innovator in intelligent, software-defined manufacturing, announced today it has raised $126 million in Series C funding.
Read More
Adonis Lands $31M Series B Funding Round
2024-06-25
NEW YORK, NY, Adonis, a leading healthcare financial technology platform based in New York City, today announced that it has raised $31 million in Series B financing.
Read More
Rocketlane Secures $24M Series B Financing
2024-06-25
SAN MATEO, CA, Rocketlane has today announced a $24 million Series B funding round.
Read More
Payabli Nabs $20M Series A Funding Round
2024-06-25
MIAMI, FL, Payabli, the payments infrastructure solution for software companies, has closed a $20 million Series A.
Read More
Exsilio Therapeutics Emerges With $82M
2024-06-25
BOSTON, MA, Exsilio Therapeutics, a biotechnology company developing genomic medicines for a broad range of diseases, announced today its emergence from stealth with $82 million in Series A financing.
Read More